RxDoctor Payments Data

Sonya Marcus, MD

Otolaryngology · Stony Brook, NYNPI 1437594058

Payments from drug & device makers

What this record shows

This record is dominated by consulting fees: $6,648 of the $9,908 with a category attached, or 67.1%. 14 manufacturers reported payments, led by GSK at 40.4% of the total. Reporting peaked in 2022 at $4,379 and has fallen 60.6% since, to $1,726 in 2025. Among otolaryngology clinicians in NY with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$9,908in general payments, 2019–2025

Across 52 payments — averaging $190.54 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • GSK$4K
  • Sanofi$3K
  • Aerin Medical Inc.$1K
  • Stryker$937
  • Regeneron Healthcare Solutions, Inc.$299
  • Optinose US, Inc.$282
  • plus $412 from 8 others
$7,700in research payments, 2019–2025

Across 2 payments — averaging $3850.00 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • GSK$8K

What the payments were for

  • Consulting fees$6,64867%
  • Travel & lodging$6026%
  • Food & beverage$2,65827%

General payments by program year

19
20
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$9,908 in reported general payments places this provider in the 90th percentile of 701 otolaryngology providers in New York.

See all otolaryngology providers in New York

Medicare billing

Part B allowed, 2024
$197,625
Medicare patients
289
Services billed
873

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Ipratropium Bromide70$1,627
Fluticasone Propionate72$801
Azelastine Hcl30$473
Doxycycline Hyclate11$130

Paid to pharmacies, not to this prescriber.

Other otolaryngology in Stony Brook

See the full list for New York

Where these figures come from

Is this you, or does something look wrong? →